{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:15Z","timestamp":1792828575461,"version":"4.5.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National High Level Hospital Clinical Research","award":["2022-PUMCH-A-064"],"award-info":[{"award-number":["2022-PUMCH-A-064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Prolactinoma, the most common subtype of pituitary adenoma, is rare in children and adolescents. Clinical presentation and treatment outcomes of prolactinomas in this population have been evaluated insufficiently.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize the clinical features, both medication and surgical outcomes of prolactinomas in children and adolescents in a large retrospective cohort from China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of patients with prolactinomas aged \u226420 years at diagnosis between 2012 and 2021 in Peking Union Medical College Hospital were retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort comprised 170 patients (115 females and 55 males, median age 16.6 years), with 20.0% (23\/115) girls without menarche and 33.3% (18\/54) boys in prepuberty. The median maximal diameter was 15.0 mm (61.2% macroadenomas and 4.6% giant adenomas), and the median baseline prolactin (PRL) level was 211.0 ng\/mL. Larger sizes and higher PRL levels were observed in girls without menarche at diagnosis and in boys. Most girls presented with menstrual disturbance (86.7%), and boys were frequently bothered by headaches (42.6%), reduced height velocities (25.9%), and delayed puberty (18.2%). Dopamine agonists (DAs) were used as first-line treatment in 133 patients, and the resistance rate was 22.5% (25\/111), independently associated with maximal tumor diameters (P = .035). Surgery was performed in 76 patients. Long-term surgical remission rates were 32.9% (25\/76) overall, negatively associated with cavernous sinus invasion independently (P = .025), 59.4% (19\/32) in noninvasive tumors (64.0% in 25 noninvasive macroadenomas), and 5.0% (1\/20) in invasive tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pediatric prolactinomas exhibited more severe clinical characteristics in boys and in patients diagnosed during earlier stages of pubertal developments. Given the overall efficacy of PRL normalization by medication and considerable surgical remission rate in noninvasive tumors, DAs remain the first-line recommendation for prolactinomas in children and adolescents, while surgery might be viable for noninvasive tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad769","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T10:53:10Z","timestamp":1703933590000},"page":"e1741-e1749","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0755-5884","authenticated-orcid":false,"given":"Yiying","family":"Yang","sequence":"first","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"},{"name":"Eight-Year Program of Clinical Medicine, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Ke","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-474X","authenticated-orcid":false,"given":"Lian","family":"Duan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-8265","authenticated-orcid":false,"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-3811","authenticated-orcid":false,"given":"Fengying","family":"Gong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2413-0646","authenticated-orcid":false,"given":"Hui","family":"Pan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-0398","authenticated-orcid":false,"given":"Linjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-6870","authenticated-orcid":false,"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College , Beijing, 100730 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"1","key":"2024081223524400400_dgad769-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2024081223524400400_dgad769-B2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024081223524400400_dgad769-B3","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024081223524400400_dgad769-B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"2024081223524400400_dgad769-B5","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1038\/s41598-021-94658-8","article-title":"Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004\u20132016","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"issue":"Supplement_3","key":"2024081223524400400_dgad769-B6","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"3","key":"2024081223524400400_dgad769-B7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024081223524400400_dgad769-B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","article-title":"Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis","volume":"177","author":"Hoffmann","year":"2018","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2024081223524400400_dgad769-B9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000486280","article-title":"Clinical features and response to treatment of prolactinomas in children and adolescents: a retrospective single-centre analysis and review of the literature","volume":"89","author":"Breil","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2024081223524400400_dgad769-B10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12020-018-1687-0","article-title":"Pediatric pituitary adenomas in northeast Mexico. A follow-up study","volume":"62","author":"Torres-Garc\u00eda","year":"2018","journal-title":"Endocrine"},{"key":"2024081223524400400_dgad769-B11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fendo.2020.00527","article-title":"Clinical, hormonal, and neuroradiological characteristics and therapeutic outcomes of prolactinomas in children and adolescents at a single center","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2024081223524400400_dgad769-B12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/cen.14394","article-title":"Prolactinoma in childhood and adolescence-Tumour size at presentation predicts management strategy: single centre series and a systematic review and meta-analysis","volume":"94","author":"Arya","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024081223524400400_dgad769-B13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11102-021-01184-x","article-title":"Management of prolactinomas in children and adolescents; which factors define the response to treatment?","volume":"25","author":"Alikasifoglu","year":"2021","journal-title":"Pituitary"},{"issue":"4","key":"2024081223524400400_dgad769-B14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/EJE-10-0519","article-title":"Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes","volume":"163","author":"Steele","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024081223524400400_dgad769-B15","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-21-0977","article-title":"Italian association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). position statement for clinical practice: prolactin-secreting tumors","volume":"186","author":"Cozzi","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024081223524400400_dgad769-B16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"2024081223524400400_dgad769-B17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/neuros\/nyy204","article-title":"Pediatric pituitary adenomas: early and long-term surgical outcome in a series of 85 consecutive patients","volume":"85","author":"Barzaghi","year":"2019","journal-title":"Neurosurgery"},{"issue":"2","key":"2024081223524400400_dgad769-B18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1227\/00006123-199402000-00001","article-title":"Transsphenoidal surgery for pituitary adenomas in children","volume":"34","author":"Dyer","year":"1994","journal-title":"Neurosurgery"},{"issue":"4","key":"2024081223524400400_dgad769-B19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01748.x","article-title":"Clinical presentation and outcome of pituitary adenomas in teenagers","volume":"58","author":"Cannav\u00f2","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024081223524400400_dgad769-B20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0090-3019(02)00714-0","article-title":"Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence","volume":"57","author":"Abe","year":"2002","journal-title":"Surg Neurol"},{"issue":"12","key":"2024081223524400400_dgad769-B21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2024081223524400400_dgad769-B22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.wneu.2016.08.088","article-title":"Cavernous Sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery","volume":"96","author":"Dhandapani","year":"2016","journal-title":"World Neurosurg"},{"issue":"4","key":"2024081223524400400_dgad769-B23","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"2024081223524400400_dgad769-B24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2010.05669.x","article-title":"Evaluation and management of adolescent amenorrhea","volume":"1205","author":"Deligeoroglou","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2024081223524400400_dgad769-B25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1109290","article-title":"Clinical practice. Delayed puberty","volume":"366","author":"Palmert","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2024081223524400400_dgad769-B26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"issue":"5","key":"2024081223524400400_dgad769-B27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024081223524400400_dgad769-B28","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy","volume":"86","author":"Di Sarno","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024081223524400400_dgad769-B29","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024081223524400400_dgad769-B30","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"1","key":"2024081223524400400_dgad769-B31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499382","article-title":"Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours","volume":"109","author":"Trouillas","year":"2019","journal-title":"Neuroendocrinology"},{"key":"2024081223524400400_dgad769-B32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fendo.2018.00706","article-title":"Sex-Related differences in lactotroph tumor aggressiveness are associated with a specific gene-expression signature and genome instability","volume":"9","author":"Wierinckx","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2024081223524400400_dgad769-B33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-21-0075","article-title":"Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas","volume":"185","author":"Mart\u00ednez de LaPiscina","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2024081223524400400_dgad769-B34","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2011-2291","article-title":"Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024081223524400400_dgad769-B35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2024081223524400400_dgad769-B36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/EJE-09-0012","article-title":"Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients","volume":"160","author":"Delgrange","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024081223524400400_dgad769-B37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024081223524400400_dgad769-B38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024081223524400400_dgad769-B39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1227\/00006123-199502000-00004","article-title":"Pediatric pituitary adenomas","volume":"36","author":"Mindermann","year":"1995","journal-title":"Neurosurgery"},{"issue":"Suppl","key":"2024081223524400400_dgad769-B40","first-page":"S95-99","article-title":"Pediatric pituitary adenoma","volume":"47","author":"Tamura","year":"2000","journal-title":"Endocr J"},{"issue":"1","key":"2024081223524400400_dgad769-B41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0317167100030109","article-title":"Pituitary adenomas in childhood and adolescence","volume":"17","author":"Maira","year":"1990","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"2024081223524400400_dgad769-B42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1227\/00006123-199110000-00004","article-title":"Pediatric pituitary tumors","volume":"29","author":"Haddad","year":"1991","journal-title":"Neurosurgery"},{"issue":"3","key":"2024081223524400400_dgad769-B43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/JPEM.2000.13.3.261","article-title":"Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches","volume":"13","author":"Fideleff","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"2024081223524400400_dgad769-B44","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s40618-021-01569-6","article-title":"First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center","volume":"44","author":"Andereggen","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024081223524400400_dgad769-B45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4158\/EP13165.RA","article-title":"Effect of the preoperative use of dopamine agonists in the postoperative course of prolactinomas: a systematic review","volume":"20","author":"Carija","year":"2014","journal-title":"Endocr Pract"},{"issue":"4","key":"2024081223524400400_dgad769-B46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2176\/nmc.35.221","article-title":"Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas","volume":"35","author":"Ekramullah","year":"1995","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"10","key":"2024081223524400400_dgad769-B47","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1210\/en.2005-0430","article-title":"Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes","volume":"146","author":"Sarkar","year":"2005","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"2024081223524400400_dgad769-B48","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1530\/eje.1.02352","article-title":"Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds","volume":"156","author":"Zatelli","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2024081223524400400_dgad769-B49","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad769\/56153989\/dgad769.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/9\/e1741\/58769773\/dgad769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/9\/e1741\/58769773\/dgad769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T21:10:00Z","timestamp":1723497000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/9\/e1741\/7504797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,1,2]]},"published-print":{"date-parts":[[2024,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad769","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,1,2]]}}}